Clinical trials
Diabetic clinical trials
Below are recruiting diabetic clinical trials, each written for real people, not researchers. We’re tracking 2,203 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06825182RecruitingPhase 3
Islet alpha cell function in new type 2 diabetes
This trial looks at how certain cells in the pancreas work in people newly diagnosed with type 2 diabetes. It may help doctors understand the disease better and find new treatment approaches.
Nanjing, JiangsuAges 18 years+ - NCT06826339RecruitingPhase 4
Advanced wound treatments for diabetic foot and leg ulcers
This study compares several advanced wound treatments (called CAMPs) plus standard care to standard care alone for hard-to-heal diabetic foot ulcers and venous leg ulcers. It aims to see if the extra treatments help wounds close faster and prevent complications.
Monroeville, PennsylvaniaAges 21 years+ - NCT06936280Recruiting
Type 1 diabetes and diabetes distress study
This trial tests a program for young adults with type 1 diabetes who feel stressed or overwhelmed by their diabetes. The goal is to see if the program can help reduce diabetes distress and improve well-being.
EsbjergAges 18–35 - NCT06984133Recruiting
Learning about diabetes for teens with type 1 diabetes
This study tests a structured education program to help Arab adolescents aged 11 to 14 better manage their blood sugar. If you have type 1 diabetes, use a continuous glucose monitor, and have not attended a diabetes education class in the last 6 months, this program may be for you.
Kuwait City, SharqAges 11–14 - NCT07089602RecruitingPhase 4
Placental membrane for diabetic and venous leg ulcers
This trial tests if a placental membrane product, when added to standard wound care, helps heal diabetic foot ulcers and venous leg ulcers faster than standard care alone.
Philidelphia, PennsylvaniaAges 18 years+ - NCT07091487Recruiting
Diabetes Homeless Medication Support Program
This study tests a program that helps people who have both type 2 diabetes and housing instability. The program supports you in taking your medication and managing your diabetes day-to-day.
Minneapolis, MinnesotaAges 18 years+ - NCT06701721RecruitingPhase 1
Study of THN391 eye injection for diabetic macular edema
This trial tests an experimental eye injection called THN391 for people with diabetic macular edema, a condition that causes vision loss due to swelling in the back of the eye. The study aims to see if the treatment is safe and may help improve vision.
Parramatta, New South WalesAges 18–80 - NCT07252700Recruiting
Prediabetes study: better care through electronic records
This trial tests if using electronic medical records can help doctors manage prediabetes better in primary care. It looks at adults with prediabetes who visit certain polyclinics and aims to prevent diabetes from developing.
SingaporeAges 21–59 - NCT07260656RecruitingEarly Phase 1
Capsaicin cream for diabetic nerve foot pain
This trial tests a new cream (Capsadyn®) made from chili pepper extract to see if it can reduce nerve pain in the feet caused by diabetes. If it works, it could offer a simple treatment you apply at home.
Roanoke, VirginiaAges 25–75 - NCT07271043Recruiting
High-protein drink for weight loss in type 2 diabetes
This study tests if a high-protein diabetes shake can help people with type 2 diabetes who are starting a new class of diabetes medications (GLP-1 or GIP receptor agonists) lose weight and improve body composition. Participants will either take the shake or a placebo drink for several weeks.
Boston, MassachusettsAges 18–75 - NCT07284511RecruitingPhase 2/Phase 3
Tirzepatide for automatic blood sugar control in type 1 diabetes
This trial tests if adding tirzepatide (a once-weekly injection) to an automated insulin pump system (Control-IQ) helps adults with type 1 diabetes better manage their blood sugar. It requires using the Tandem Control-IQ pump and counting carbohydrates.
Montreal, QuebecAges 18 years+ - NCT07197775Enrolling by invitation
Endogenex PULSE Registry: Tracking long-term outcomes
This registry collects information from people with type 2 diabetes who have already been treated with the Endogenex System. It helps researchers learn how the treatment works over time.
Quincy, MassachusettsAges 18 years+ - NCT07391995Recruiting
New test for bacteria in diabetic foot infections
This trial tests a new portable device called MinION that can quickly identify bacteria in foot wounds of people with diabetic foot bone infections. It aims to help doctors choose the right antibiotic faster.
Nîmes, GardAges Any age - NCT01055093Recruiting
Study of diabetes complications in adults soon after diagnosis
This study follows adults who have been diagnosed with diabetes recently to better understand diabetes and its complications over time. It also includes a comparison group of people who do not have diabetes to help researchers see what changes are linked to diabetes.
Düsseldorf, North Rhine-WestphaliaAges 18–69 - NCT03161652RecruitingPhase 2
Levosulpiride for diabetic eye swelling and retinopathy
This Phase 2 study tests whether levosulpiride can improve changes in the retina in people with diabetic retinopathy and diabetic macular edema (eye swelling that can affect vision). It may help by targeting chemicals in the body that could affect eye tissue and inflammation.
Querétaro City, QuerétaroAges 40–69 - NCT07434154Recruiting
Comparing oxidative stress in type 1 diabetes and LADA
This study looks at oxidative stress—a type of cell damage—in people with type 1 diabetes or LADA. It may help explain how these conditions affect the body and guide future care.
Pavia, PaviaAges 18–75 - NCT07492004Recruiting
China Registry for Genetic Diabetes
This registry is for people who may have a genetic form of diabetes (monogenic diabetes) diagnosed at a young age. It collects information to better understand and diagnose these rare diabetes types.
TianjinAges Any age - NCT07498218RecruitingPhase 1
Studying VELGRAFT for diabetic foot ulcers
This trial tests a new treatment called VELGRAFT, which is made from living cells, for diabetic foot ulcers that haven't healed with standard care. The goal is to see if it can help the wound close and heal more effectively.
Phoenix, ArizonaAges 18 years+ - NCT07558863RecruitingPhase 4
GLP-1 medication's effect on nerve damage in type 2 diabetes
This study tests whether a GLP-1 medication (a type of diabetes drug) can help protect nerves in the heart from damage caused by diabetes. If you have type 2 diabetes and are overweight, this trial might help researchers understand if this medication improves how your heart's nervous system works.
Nanjing, JiangsuAges 18–70 - NCT07621445Recruiting
Understanding Genetic Risk in Recently Diagnosed Diabetes
This study looks at genetic factors in people recently diagnosed with diabetes to understand what might predict who needs insulin treatment. Researchers will analyze blood samples and medical information to see if genetic testing could help doctors predict your treatment path.
Changsha, HunanAges 14–50 - NCT07650318Recruiting
VR Cognitive Training for Type 2 Diabetes and Memory Problems
This study tests whether virtual-reality brain-training games can help people with type 2 diabetes who are experiencing early memory and thinking problems. Researchers will compare how cognition changes in people using VR training versus standard care over several months.
Nanjing, JiangsuAges 45–80 - NCT07126197Enrolling by invitation
Lymphovenous bypass for diabetic nerve pain
This study tests if a surgery called lymphovenous bypass can reduce nerve pain caused by diabetes. It may help people with diabetic peripheral neuropathy, even if they have foot ulcers.
TaipeiAges 20–80 - NCT07107789Enrolling by invitation
Can animated videos help kids with type 1 diabetes?
This study tests whether watching short education videos with animations can help children with type 1 diabetes better manage their blood sugar, take care of themselves, and feel more positive about their condition. It's for kids aged 11 to 18 who use an insulin pen.
Erzurum, PalandökenAges 11–18 - NCT07038213Enrolling by invitation
Study of kidney protection in type 2 diabetes
This study looks at how genes may affect kidney disease in people with type 2 diabetes. It tests treatments to protect the kidneys. If you are of Kazakh ethnicity and have type 2 diabetes, you may be able to join.
AstanaAges 18–65
Hear when a new Diabetic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetic?
- Yes. Clin2 currently lists 2,203 recruiting diabetic studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetic trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetic trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.